Internal Medicine, Infectious Disease · Houston, TX
NPI
1104051853
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1415 California St
Houston, TX, 77006
Phone (832) 548-5000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.2M
1,112 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rubina Y Joseph prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 214 prescriptions and refills. In total Rubina Y Joseph wrote 1,112 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 214 | 214 | 36 | $822K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 78 | 78 | 11 | $280K |
| Atorvastatin Calcium Generic | 75 | 175 | 24 | $479 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 63 | 63 | Under 11 | $290K |
| Amlodipine Besylate Generic | 42 | 91 | 12 | $221 |
| Tivicay Dolutegravir Sodium | 41 | 41 | 11 | $91K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 39 | 47 | Under 11 | $191K |
| Juluca Dolutegravir/Rilpivirine | 29 | 29 | Under 11 | $97K |
| Descovy Emtricitabine/Tenofov Alafenam | 27 | 27 | Under 11 | $58K |
| Prezcobix Darunavir/Cobicistat | 26 | 26 | Under 11 | $63K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 23 | 23 | Under 11 | $79K |
| Hydrochlorothiazide Generic | 22 | 44 | Under 11 | $43.73 |
| Dovato Dolutegravir Sodium/Lamivudine | 21 | 21 | Under 11 | $58K |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 18 | 27 | Under 11 | $3,687 |
| Metoprolol Tartrate Generic | 18 | 24 | Under 11 | $29.72 |
Brand drugs: 642 claims; generic drugs: 470 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rubina Y Joseph were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.